Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials.
about
Evolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease.Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease.The interplay between CKD, sudden cardiac death, and ventricular arrhythmiasPrimary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study.Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysisEffect of Advancing Age and Multiple Chronic Conditions on Mortality in Patients with End-Stage Renal Disease after Implantable Cardioverter-Defibrillator Placement.Influence of renal function on mortality and ventricular arrhythmias in patients undergoing first implantable cardioverter-defibrillator generator replacement.National Trends in the Use of Cardiac Resynchronization Therapy With or Without Implantable Cardioverter-Defibrillator.Sudden cardiac death in end stage renal disease: unlocking the mystery.Sudden cardiac death in CKD patients.Clinical Outcomes in Dialysis Patients: Prospects for Improvement with Aldosterone Receptor Antagonists.The impact of changes in LVEF and renal function on the prognosis of ICD patients after elective device replacement.Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future.Mortality reduction by post-dilution online-haemodiafiltration: a cause-specific analysis.Sudden Cardiac Death Among Hemodialysis Patients.Kidney function and sudden cardiac death in the community: The Atherosclerosis Risk in Communities (ARIC) Study.Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators.[In Germany too many ICD implantations are performed: pro].Identifying patients with less potential to benefit from implantable cardioverter-defibrillator therapy: comparison of the performance of four risk scoring systems.Long-term survival of implantable cardioverter defibrillator recipients with end-stage renal disease.Shades of grey: the conundrum of implantable defibrillators in individuals with advanced CKDNew York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials.Do implantable defibrillators help patients with CKD?Comparative effectiveness of cardiac implantable electrical devices.Prescription of Guideline-Recommended Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Among Patients Hospitalized With Heart Failure and Varying Degrees of Renal Function.Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease.Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceChronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm S
P2860
Q30234797-8FD17466-7890-4627-89E0-B3E2366AAC2DQ34388998-D321F64F-2A45-4478-8556-4DA367A1C021Q34629381-2C93E867-89D3-4665-8DBA-CD07790D8C91Q35587006-B85D6B78-2FEB-41A8-A37D-571BDB15F308Q35817055-8F3E6F44-E772-49AE-B99C-8929BA19098CQ36520059-D2BA2E9A-6230-4AF9-9A45-FAA6AB76303AQ36543635-B0A49A63-2937-40DB-A20E-F4666A1F26F7Q37602252-BC523BAC-56BD-44F4-848F-B864690CAA85Q38267707-7B55A96C-3B6B-408C-BEE1-812F282C9F90Q38473007-92A40816-7666-4F5B-B56B-8AE10BB84F59Q38560705-29EED96E-0757-4AED-B2B5-EA078DC470DDQ38635189-0D27F681-961D-4DEC-BB98-BD3455DFFD63Q38659406-AC33060C-3949-431D-ACDC-5052EF76EF3EQ39063242-6255BE01-5136-4992-9BC3-8C4E111B66D8Q39145628-6EE1C830-2EB2-4B1D-B4CE-CE0523CE2603Q39360096-8337993A-FDB4-4739-985D-A5FDB8341BC2Q40541362-11ECECE7-2786-42EF-AC40-864F02F7E109Q40914520-2EEC23C4-541E-49E2-99A5-30E28E98CEABQ41051372-5945F0C7-EBFD-44A2-A24B-FA3D2317D194Q42266023-51EEF034-0D91-46D2-B2A0-FB4E0B1C4C6BQ42362485-31110EE8-B4FA-4C57-BF16-218C9FCF3E57Q42689418-89ABDEFD-9534-46FC-ADAC-268237123A91Q42767794-7037DBF0-E770-483B-B0A7-F8B6BD9B19B2Q43107253-10B933E7-D0E7-4B2A-A186-F1017D5929A5Q46160078-3EA2966E-2088-4E8F-95BC-7AC857E34936Q50195020-537B3588-F620-4D7F-92BA-81482AC7B398Q52587533-52B63F8D-15FA-47E8-9A90-C33A72845325Q57750151-21556CEF-4D2D-4575-B9D8-D2BC77DFDD99Q58492145-9040032E-92F1-4942-82C4-37807714B9F1
P2860
Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Implantable cardioverter-defib ...... data from 3 randomized trials.
@ast
Implantable cardioverter-defib ...... data from 3 randomized trials.
@en
type
label
Implantable cardioverter-defib ...... data from 3 randomized trials.
@ast
Implantable cardioverter-defib ...... data from 3 randomized trials.
@en
prefLabel
Implantable cardioverter-defib ...... data from 3 randomized trials.
@ast
Implantable cardioverter-defib ...... data from 3 randomized trials.
@en
P2093
P2860
P50
P1476
Implantable cardioverter-defib ...... data from 3 randomized trials.
@en
P2093
Al Hallstrom
Alan H Kadish
Alfred E Buxton
Arthur J Moss
J Thomas Bigger
Joo Yoon Han
Lurdes Y T Inoue
Patrick H Pun
Paul Dorian
Paul L Hess
P2860
P356
10.1053/J.AJKD.2013.12.009
P577
2014-02-08T00:00:00Z